Search research articles
Contact Us
Filters
Showing results (1451-1460 of 1,472) with videos related to
Page
of 148
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
Anandan Palani, Ashwin U Rao, Xiao Chen, et al.
Journal of the American Chemical Society
|
December 13, 2018
Energy-Degeneracy-Driven Covalency in Actinide Bonding
Jing Su, Enrique R Batista, Kevin S Boland, et al.
Diabetes, Obesity & Metabolism
|
January 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study
Gui-Ling Chen, Yang Liu, Xue-Feng Gao, et al.
International Journal of Hypertension
|
September 21, 2020
Blood Pressure Variability during Angiography in Patients with Ischemic Stroke and Intracranial Artery Stenosis
Hui Pan, Rong Zhao, Feng-Di Liu, et al.
Science Translational Medicine
|
March 11, 2016
TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci
Sang Ho Lee, Hao Wang, Marc Labroli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery
Emory R McTyre, Michael H Soike, Michael Farris, et al.
Journal of Biotechnology
|
September 5, 2017
Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening
Wei Yang, Søren Berg Padkjær, Jishu Wang, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Nature
|
November 18, 2021
Isolation and characterization of a californium metallocene
Conrad A P Goodwin, Jing Su, Lauren M Stevens, et al.
Page
of 148
Search research articles
Search
Showing results (1451-1460 of 1,472) with videos related to
Sort By:
Page
of 148
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
Anandan Palani, Ashwin U Rao, Xiao Chen, et al.
Journal of the American Chemical Society
|
December 13, 2018
Energy-Degeneracy-Driven Covalency in Actinide Bonding
Jing Su, Enrique R Batista, Kevin S Boland, et al.
Diabetes, Obesity & Metabolism
|
January 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study
Gui-Ling Chen, Yang Liu, Xue-Feng Gao, et al.
International Journal of Hypertension
|
September 21, 2020
Blood Pressure Variability during Angiography in Patients with Ischemic Stroke and Intracranial Artery Stenosis
Hui Pan, Rong Zhao, Feng-Di Liu, et al.
Science Translational Medicine
|
March 11, 2016
TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci
Sang Ho Lee, Hao Wang, Marc Labroli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery
Emory R McTyre, Michael H Soike, Michael Farris, et al.
Journal of Biotechnology
|
September 5, 2017
Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening
Wei Yang, Søren Berg Padkjær, Jishu Wang, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
Nature
|
November 18, 2021
Isolation and characterization of a californium metallocene
Conrad A P Goodwin, Jing Su, Lauren M Stevens, et al.
Page
of 148